James M. Frincke
Plus aucun poste en cours
Profil
James M.
Frincke served as Vice President of Research & Development at Eli Lilly & Co., Hybritech, Inc., and Systemix, Inc. He was also President, CEO & Director at Harbor Diversified, Inc. and Chief Technical Officer at Premier Biomedical, Inc. Additionally, he served as VP of Therapeutics Research & Development at Prolinx, Inc. Frincke received his undergraduate and doctorate degrees from the University of California, Davis.
Anciens postes connus de James M. Frincke
| Sociétés | Poste | Fin |
|---|---|---|
| Prolinx, Inc. | Directeur Technique/Scientifique/R&D | 01/01/1997 |
Systemix, Inc.
 Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Directeur Technique/Scientifique/R&D | 01/06/1995 |
Hybritech, Inc.
 Hybritech, Inc. Miscellaneous Commercial ServicesCommercial Services Hybritech, Inc. provides prostate diagnostic testing services. The company is headquartered in San Diego, CA. | Directeur Technique/Scientifique/R&D | 01/02/1991 |
| ELI LILLY AND COMPANY | Directeur Technique/Scientifique/R&D | 01/02/1991 |
| PREMIER BIOMEDICAL, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de James M. Frincke
| University of California, Davis | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| HARBOR DIVERSIFIED, INC. | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| PREMIER BIOMEDICAL, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Prolinx, Inc. | |
Hybritech, Inc.
Hybritech, Inc. Miscellaneous Commercial ServicesCommercial Services Hybritech, Inc. provides prostate diagnostic testing services. The company is headquartered in San Diego, CA. | Commercial Services |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Health Services |
